These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-000877-23 Is Remifentanil better than Propofol in providing optimal conditions for an awake fibreoptic intubation? not-yet-due
Ongoing 2005-001693-27 Pilot Effectiveness of Randomised Mandatory Insulin Therapy not-yet-due
Ongoing 2005-001834-34 Phase 2 trial of neo-adjuvant Oxaliplatin and 5-fluorouracil in oesophageal cancer not-yet-due
Ongoing 2005-003438-17 SimSepT: Simvastatin and severe sepsis in the ICU not-yet-due
Other 2005-003496-20 The effect of pre-operative Octreotide LAR treatment on surgical cure rates of subjects with Acromegaly, and post-operative responsiveness to somatostatin analogue treatment in patients not cured surg... not-yet-due
Ongoing 2005-004102-90 Efficacy and safety of amiodarone 100mg versus 200mg for the maintenance of sinus rhythm after cardioversion of atrial fibrillation not-yet-due
Ongoing 2005-004209-27 Effect of altering inspired oxygen concentrations on cerebral oxygenation during awake carotid surgery not-yet-due
Ongoing 2005-004372-20 A randomised, prospective,open-label, multi-centre study comparing the efficacy and safety of conversion to Sirolimus in stable renal transplant recipients with a cutaneous squamous cell carcinoma. not-yet-due
Ongoing 2006-001094-15 Dose-banding of carboplatin: Effect on area under the plasma concentration - time curve (AUC) compared with individualised dosing not-yet-due
Ongoing 2007-001264-72 A Phase II Trial of Erlotinib as first line therapy in Non- Small Cell Lung Cancer over-expressing EGFR not-yet-due
Not reported 2007-002132-29 A Phase II Trial of Sorafenib (a tyrosine kinase inhibitor) given orally twice daily in renal cancer patients with vHL syndrome 2011-02-15 due-trials
Not reported 2007-004051-11 Amiloride Treatment in Multiple Sclerosis 2010-12-01 due-trials
Not reported 2008-000073-37 Assessment of the effects of pressors on graft blood flow after free tissue transfer surgery 2010-02-17 due-trials
Ongoing 2009-015533-79 An assessment of the effects of pressors on graft blood flow after free tissue transfer surgery: A randomised study – Part II not-yet-due
Not reported 2009-015744-42 Randomized open label study of oral versus intravenous antibiotic treatment for bone and joint infections requiring prolonged antibiotic treatment: Preliminary study in a single centre. 2013-04-11 due-trials
Ongoing 2010-018596-24 Assessment of Salmonella Typhim Vi(TM) vaccine (Sanofi Pasteur MSD) for the investigation of selective antibody deficiency to polysaccharide. not-yet-due
Reported results 2010-021284-33 Proof of concept study of combined allergen immunotherapy and antibiotics for the treatment of chronic atopic eczema 2013-03-31 due-trials
Ongoing 2010-022812-37 A phase 2 trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma not-yet-due
Ongoing 2010-024552-28 BRUISE CONTROL : BRidge or continUe coumadIn for device SurgEry randomized CONTROLled Trial not-yet-due
Other 2011-000990-29 Multinational european trial for children with the opsoclonus myoclonus syndrome/dancing eye syndrome. not-yet-due
Ongoing 2011-002028-41 A study to determine regional lung function in patients with Non-small cell lung cancer (NSCLC) undegoing radiotherapy using hyperpolarised xenon gas MR imaging not-yet-due
Ongoing, reported early 2011-002833-20 Prospective study of 18F-RGD PET-CT in assessment of response to antiangiogenic treatment in patients with renal cancer and comparison with perfusion CT not-yet-due
Reported results 2013-004205-89 Randomized multicentre pilot study of LCZ696 versus irbesartan in patients with chronic kidney disease: UK Heart and Renal Protection (HARP)-III 2017-03-02 due-trials